Smith Carol E, Piamjariyakul Ubolrat, Wick Jo A, Spertus John A, Russell Christy, Dalton Kathleen M, Elyachar Andrea, Vacek James L, Reeder Katherine M, Nazir Niaman, Ellerbeck Edward F
From the School of Nursing (C.E.S., U.P.), School of Medicine, Department of Preventive Medicine and Public Health (C.E.S., A.E., N.N., E.F.E.), Department of Biostatistics (J.A.W.), University of Kansas Medical Center, Kansas City, KS; School of Medicine, Department of Cardiovascular Medicine, University of Missouri Kansas City, Saint Luke's Mid America Heart Institute, Kansas City, MO (J.A.S.); Department of Mid America Cardiology, University of Kansas Hospital (C.R., K.M.D., J.L.V.), and School of Medicine, Department of Cardiovascular Medicine (J.L.V.), Kansas City, KS; and Goldfarb School of Nursing, Barnes Jewish College, St Louis, MO (K.M.R.).
Circ Heart Fail. 2014 Nov;7(6):888-94. doi: 10.1161/CIRCHEARTFAILURE.113.001246. Epub 2014 Sep 18.
This trial tested the effects of multidisciplinary group clinic appointments on the primary outcome of time to first heart failure (HF) rehospitalization or death.
HF patients (n=198) were randomly assigned to standard care or standard care plus multidisciplinary group clinics. The group intervention consisted of 4 weekly clinic appointments and 1 booster clinic at month 6, where multidisciplinary professionals engaged patients in HF self-management skills. Data were collected prospectively for 12 months beginning after completion of the first 4 group clinic appointments (2 months post randomization). The intervention was associated with greater adherence to recommended vasodilators (P=0.04). The primary outcome (first HF-related hospitalization or death) was experienced by 22 (24%) in the intervention group and 30 (28%) in standard care. The total HF-related hospitalizations, including repeat hospitalizations after the first time, were 28 in the intervention group and 45 among those receiving standard care. The effects of treatment on rehospitalization varied significantly over time. From 2 to 7 months post randomization, there was a significantly longer hospitalization-free time in the intervention group (Cox proportional hazard ratio=0.45 (95% confidence interval, 0.21-0.98; P=0.04). No significant difference between groups was found from month 8 to 12 (hazard ratio=1.7; 95% confidence interval, 0.7-4.1).
Multidisciplinary group clinic appointments were associated with greater adherence to selected HF medications and longer hospitalization-free survival during the time that the intervention was underway. Larger studies will be needed to confirm the benefits seen in this trial and identify methods to sustain these benefits.
http://www.clinicaltrials.gov. Unique identifier: NCT00439842.
本试验测试了多学科团队门诊预约对首次心力衰竭(HF)再住院或死亡时间这一主要结局的影响。
HF患者(n = 198)被随机分配至标准治疗组或标准治疗加多学科团队门诊组。团队干预包括每周进行4次门诊预约,并在第6个月进行1次强化门诊,多学科专业人员指导患者掌握HF自我管理技能。从首次4次团队门诊预约完成后(随机分组后2个月)开始,前瞻性收集12个月的数据。干预与对推荐血管扩张剂的更高依从性相关(P = 0.04)。干预组有22例(24%)出现主要结局(首次HF相关住院或死亡),标准治疗组有30例(28%)。包括首次住院后的再次住院在内,干预组HF相关住院总数为28次,接受标准治疗的患者为45次。治疗对再住院的影响随时间有显著差异。随机分组后2至7个月,干预组无住院时间显著更长(Cox比例风险比 = 0.45(95%置信区间,0.21 - 0.98;P = 0.04)。8至12个月时两组间未发现显著差异(风险比 = 1.7;95%置信区间,0.7 - 4.1)。
多学科团队门诊预约与对选定HF药物的更高依从性以及干预进行期间更长的无住院生存期相关。需要更大规模的研究来证实本试验中观察到的益处,并确定维持这些益处的方法。